tiprankstipranks
Trending News
More News >

OptimizeRx sees FY25 adjusted EBITDA at least $12M

The Company is providing full year 2025 guidance and expects revenue to be at least $100 million with an Adjusted EBITDA of at least $12 million.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue